MedPath
TGA Approval

HYRIMOZ adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe (407872)

407872

HYRIMOZ adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe

Sandoz Pty Ltd

May 15, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/844208fc05e5f943990d8d657657ece4.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/597eeaa5096c6786e670407cbc37b987.pdf

Active Ingredients

Adalimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYRIMOZ adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe (407872) - TGA 批准文号 | MedPath